Diabetes Research and Clinical Practice
Volume 87, Issue 3 , Pages 360-365, March 2010

Impact of type 2 diabetes mellitus on prescription medication burden and out-of-pocket healthcare expenses☆

  • Helena W. Rodbard

      Affiliations

    • Endocrine and Metabolic Associates, Rockville, MD, USA
    • ,
  • Andrew J. Green

      Affiliations

    • Midwestern Endocrinology, Overland Park, KS, USA
    • ,
  • Kathleen M. Fox

      Affiliations

    • Strategic Healthcare Solutions, LLC, Monkton, MD, USA
    • Corresponding Author InformationCorresponding author at: P.O. Box 543, Monkton, MD 21111, USA. Tel.: +1 443 690 2198; fax: +1 410 357 8018.
    • ,
  • Susan Grandy

      Affiliations

    • AstraZeneca Pharmaceuticals LP, Wilmington, DE, USA
    • ,
  • for the SHIELD Study Group

Received 31 July 2009; received in revised form 24 November 2009; accepted 30 November 2009. published online 04 January 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ This research was supported by AstraZeneca Pharmaceuticals LP.

PII: S0168-8227(09)00492-6

doi:10.1016/j.diabres.2009.11.021

Diabetes Research and Clinical Practice
Volume 87, Issue 3 , Pages 360-365, March 2010

Article Tools

* Image Usage & Resolution